Fanconi-Albertini-Zellweger syndrome: Difference between revisions
Jump to navigation
Jump to search
m Robot: Automated text replacement (-msbeih@perfuse.org +msbeih@wikidoc.org, -psingh@perfuse.org +psingh13579@gmail.com, -agovi@perfuse.org +agovi@wikidoc.org, -rgudetti@perfuse.org +ravitheja.g@gmail.com, -lbiller@perfuse.org +lbiller@wikidoc.org,... |
Rim Halaby (talk | contribs) |
||
Line 3: | Line 3: | ||
{{SI}} | {{SI}} | ||
Fanconi-Albertini-Zellweger syndrome is a rare syndrome that is typically characterized by [[congenital heart defect]]s, brain abnormalities, [[osteoporosis]], blood abnormalities, unusual facial characteristics, and [[metabolic acidosis]]. | |||
==References== | ==References== |
Latest revision as of 20:39, 1 August 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2], Raviteja Guddeti, M.B.B.S.[3]
Fanconi-Albertini-Zellweger syndrome is a rare syndrome that is typically characterized by congenital heart defects, brain abnormalities, osteoporosis, blood abnormalities, unusual facial characteristics, and metabolic acidosis.